drugset / Trial / NCT01770886
A Phase I Study of Oral UE2343 in Healthy Subjects
Phase 1
Completed
48 enrolled
University of Edinburgh
Simbec Research · collabWellcome Trust · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A randomised, double-blind, placebo-controlled, phase I study in healthy subjects. Safety, pharmacokinetic and pharmacodynamic data will be collected.
Timeline
- Start
- 2013-01
- Primary completion
- 2013-07
- Completion
- 2013-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EMESTEDASTAT | Small molecule | — | Oral |
Indications
No indication recorded.